revaccination
Showing 1 - 25 of 122
Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders
Completed
- HIV Infections
- +2 more
-
Baltimore, Maryland
- +1 more
Mar 17, 2023
Splenectomised Patients Trial in Paris (Prevenar13 (PCV13) and Pneumovax (PPS23), Placebo / Pneumovax (PPS23), Blood sample)
Active, not recruiting
- Splenectomised Patients
- Prevenar13 (PCV13) and Pneumovax (PPS23)
- +2 more
-
Paris, FranceCIC 1417 Cochin-Pasteur - GH Broca-Cochin-Hôtel-Dieu
Oct 10, 2022
Hepatitis B, Vaccination; Infection, Preventable Disease, Vaccine Trial in Taipei (recombinant hepatitis B vaccine)
Recruiting
- Hepatitis B
- +2 more
- recombinant hepatitis B vaccine
-
Taipei, TaiwanFamily Medicine, NTUH
Jun 24, 2022
Tuberculosis Infection, Tuberculosis Trial (BCG vaccine, Oral Chemoprophylaxis)
Not yet recruiting
- Tuberculosis Infection
- Tuberculosis
- BCG vaccine
- Oral Chemoprophylaxis
- (no location specified)
Jul 4, 2022
Tuberculosis, HIV Trial in South Africa (VPM1002 Vaccine, BCG Vaccine, Placebo)
Not yet recruiting
- Tuberculosis
- HIV Infections
- VPM1002 Vaccine
- +2 more
-
Johannesburg, Gauteng, South Africa
- +8 more
Sep 14, 2022
CLL, Vaccine Response Trial in Örebro (PCV13, PPSV23)
Active, not recruiting
- CLL
- Vaccine Response
- PCV13
- PPSV23
-
Örebro, SwedenMagdalena Kättström
Mar 29, 2022
Respiratory Syncytial Virus Infections Trial in Belgium, United States (RSVPreF3 OA investigational vaccine (GSK3844766A))
Completed
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine (GSK3844766A)
-
Lenexa, Kansas
- +9 more
Jun 2, 2022
Tuberculosis Trial in South Africa (BCG vaccine SSI, Placebo)
Active, not recruiting
- Tuberculosis
- BCG vaccine SSI
- Placebo
-
Klipfontein, Cape Town, South Africa
- +4 more
Aug 10, 2021
Vaccination; Infection, COVID-19 Trial in Leiden (solid microneedle skin patch, mRNA-1273, standard needle)
Recruiting
- Vaccination; Infection
- COVID-19
- solid microneedle skin patch
- +2 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 14, 2022
Pneumococcal Infections Trial in Seoul (ProDiax-23 (PPSV23))
Not yet recruiting
- Pneumococcal Infections
- ProDiax-23 (PPSV23)
-
Seoul, Korea, Republic ofKoera University Guro Hospital
May 3, 2021
Invasive Pneumococcal Disease Trial in Hringbraut, Reykjavik (13-valent pneumococcal conjugate vaccine (13vPnC), Blood draw)
Completed
- Invasive Pneumococcal Disease
- 13-valent pneumococcal conjugate vaccine (13vPnC)
- Blood draw
-
Hringbraut, Reykjavik, Iceland
- +1 more
Oct 14, 2021
Avian Influenza, Influenza Immunisation Trial in United States (biological, drug, other)
Completed
- Avian Influenza
- Influenza Immunisation
- A/H7N9
- +2 more
-
Atlanta, Georgia
- +8 more
Jul 8, 2021
Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA investigational vaccine)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
-
Mobile, Alabama
- +45 more
Jul 22, 2022
Pediatric Cancer Trial in Charlotte (Vaccine)
Recruiting
- Pediatric Cancer
- Vaccine
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 27, 2023
Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention Trial in Worldwide (RSV preF-based Vaccine,
Recruiting
- Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention
- RSV preF-based Vaccine
- Placebo
-
Long Beach, California
- +27 more
Jan 17, 2023
Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))
Not yet recruiting
- Transplantation, Hematopoietic Stem Cell
- Biological samples (blood and oral fluid)
-
Lyon, FranceHôpital de la Croix Rousse - service des maladies infectieuses e
Jul 7, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Pneumococcal 13-valent Conjugate Vaccine,
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pneumococcal 13-valent Conjugate Vaccine
- Pneumococcal Polyvalent Vaccine
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 10, 2022
Tuberculosis Trial in Cape Town (H4:IC31, H56:IC31, BCG)
Completed
- Tuberculosis
- H4:IC31
- +3 more
-
Cape Town, South AfricaDesmond Tutu HIV Foundation
Oct 28, 2019
Latent Tuberculosis Trial in Dourados (BCG)
Not yet recruiting
- Latent Tuberculosis
- BCG
-
Dourados, Mato Grosso Do Sul, BrazilRoberto Oliveira
Sep 13, 2022
Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])
Recruiting
- Influenza
- +3 more
- Influenza vaccine [inactivated]
-
Ekaterinburg, Russian Federation
- +6 more
Feb 13, 2023
Tuberculosis Trial in Cape Town, Nyanga (AERAS-404, Placebo, Bacillus Calmette-Guérin (BCG))
Completed
- Tuberculosis
- AERAS-404
- +2 more
-
Cape Town, Western Cape, South Africa
- +1 more
Aug 22, 2019
Influenza, Human, Vaccination; Infection, Vaccines Trial in Saint Petersburg (Flu-M, Inactivated split influenza vaccine 0.5 mL,
Completed
- Influenza, Human
- +2 more
- Flu-M, Inactivated split influenza vaccine 0.5 mL
- +3 more
-
Saint Petersburg, Russian Federation
- +1 more
Jul 19, 2022
Influenza, Influenza, Human Trial in Wilrijk (Influenza Vaccine GSK1247446A, Fluarix™)
Completed
- Influenza
- Influenza, Human
- Influenza Vaccine GSK1247446A
- Fluarix™
-
Wilrijk, BelgiumGSK Investigational Site
Jun 13, 2019
HIV I Infection, Tuberculosis Trial in South Africa (MTBVAC, BCG)
Not yet recruiting
- HIV I Infection
- Tuberculosis
- MTBVAC
- BCG
-
Westdene, Gauteng,, South Africa
- +15 more
Jul 21, 2023
Covid19, Morbidity, Absenteeism Trial in Bissau, Manhiça (BCG-Denmark, Saline)
Completed
- Covid19
- +2 more
- BCG-Denmark
- Saline
-
Bissau, SAB, Guinea-Bissau
- +1 more
Nov 2, 2022